MedTrace Logo

Foot and Ankle Clinic Application for Liposomal Related Anesthetic

NCT02586077 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-10-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to review the use of surgeon applied liposomal release anesthetic (Exparel) for post operative analgesia.

Hypothesis: Surgeon applied use of liposomal related anesthetic provides excellent post operative analgesia. Immediated and 72 hour narcotic use will be significantly impacted by the use of this modality.

Conditions

  • Ankle Arthrodesis
  • Hindfoot Arthrodesis
  • Tibitalocalceal Arthrodesis

Interventions

DRUG

Exparel

Sponsors & Collaborators

  • Pacira Pharmaceuticals, Inc

    collaborator INDUSTRY

  • OrthoCarolina Research Institute, Inc.

    lead OTHER

Principal Investigators

  • Susan M Odum, PhD · OrthoCarolina Research Institute

  • Bruce Cohen, MD · OrthoCarolina Foot & Ankle Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-01
Primary Completion
2016-06-30
Completion
2016-11-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02586077 on ClinicalTrials.gov